Identification of Chagas disease biomarkers using untargeted metabolomics-Reference-Cited by-同舟云学术

Identification of Chagas disease biomarkers using untargeted metabolomics

Published:2024-08-13 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Herreros-Cabello Alfonso,Bosch-Nicolau Pau,Pérez-Molina José A.,Salvador Fernando,Monge-Maillo Begoña,Rodriguez-Palomares Jose F.,Ribeiro Antonio Luiz Pinho,Sánchez-Montalvá Adrián,Sabino Ester Cerdeira,Norman Francesca F.,Fresno Manuel,Gironès Núria,Molina Israel

Funder

Proyectos de investigación en salud, Instituto Carlos III, Ministry of Science, Innovation and Universities, Spanish Government

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-69205-w.pdf

Reference37 articles.

1. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 90, 33–43 (2015).

2. Pérez-Molina, J. A. & Molina, I. Chagas disease. Lancet 391, 82–94 (2018).

3. Maron, B. J. et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807–1816 (2006).

4. Sales, P. A. et al. Experimental and clinical treatment of chagas disease: A review. Am. J. Trop Med. Hyg. 97, 1289–1303 (2017).

5. Crespillo-Andújar, C. et al. Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis. PLoS Negl. Trop Dis. 16, e0010386 (2022).